Brown-Forman Corporation (NYSE:BF-B), the maker of Jack Daniel’s, warned that alcohol demand in developed markets is likely to remain weak through fiscal 2027. The company reported first-quarter net sales of $911 million, down 1% year over year and slightly below analysts’ expectations of $914.9 million. Despite the sales miss, adjusted earnings of $0.38 per share beat estimates of $0.37, and management maintained its full-year outlook for flat organic sales and a 3%–5% decline in organic operating income.
The biggest concern is that weakness appears broad rather than limited to one brand. Brown-Forman Corporation (NYSE:BF-B) said U.S. consumers are becoming more cautious with spending, while health-conscious behavior and growing GLP-1 use are also affecting alcohol consumption. Demand has also softened in developed international markets such as Germany, France and the UK.
Canada remains another major headwind. US-made spirits are still absent from shelves in most Canadian provinces, and Brown-Forman’s CEO expects this situation to continue for the rest of the fiscal year.
Brown-Forman Has Growth Opportunities Despite Weak Alcohol Demand
Brown-Forman Corporation (NYSE:BF-B) still has several areas of the portfolio showing strong momentum. Its ready-to-drink business grew 20% in the quarter, with New Mix particularly strong. The company has also been using new products such as Jack Daniel’s Tennessee Blackberry to offset weakness in its traditional spirits portfolio.
The earnings beat is another positive. Although revenue missed expectations, Brown-Forman Corporation (NYSE:BF-B) expanded gross margin by 40 basis points and reported stronger operating cash flow and free cash flow. This suggests management is finding ways to protect profitability even while sales remain under pressure.
There is also a potential recovery opportunity in Canada. If trade tensions ease and American spirits return to Canadian shelves, Brown-Forman could regain lost sales without requiring a major increase in consumer spending. At the same time, its emerging-market business has shown considerably better growth, providing an opportunity to reduce reliance on weaker developed markets.
Weak Alcohol Demand Could Keep Pressure on Brown-Forman
The biggest risk is that the weakness in alcohol consumption becomes a longer-term structural problem rather than a temporary slowdown. Brown-Forman Corporation (NYSE:BF-B) is facing tighter consumer budgets, greater health awareness, and changing drinking habits, particularly among younger consumers. Barron’s has also highlighted the broader weakness across beer and spirits, suggesting the pressure is affecting the industry rather than Brown-Forman alone.
The company’s core whiskey business is not providing enough growth to fully offset weakness elsewhere. Whiskey sales were flat in the latest quarter, while tequila sales fell 12%. Herradura and el Jimador were both under pressure, showing that Brown-Forman’s diversification outside Jack Daniel’s is currently not translating into consistent growth.
Canada creates another significant downside risk. With U.S.-made spirits expected to remain off shelves in most provinces for the rest of the fiscal year, the company could continue losing sales in an important international market. Meanwhile, the planned retirement of CEO Lawson Whiting adds uncertainty at a time when the company is already trying to navigate weak demand and changing consumer preferences.
Conclusion
The outlook for Brown-Forman Corporation (NYSE:BF-B) remains mixed but leans cautious. The company has strong brands, improving RTD momentum, healthy cash generation, and some growth opportunities in emerging markets. The latest earnings beat also shows that management can defend margins despite weak demand.
Still, the larger issue is that the pressure is affecting multiple markets and product categories. With developed-market consumption weakening, tequila sales falling and Canada likely remaining a drag, Brown-Forman may struggle to generate meaningful top-line growth in the near term.
Overall, the bull case depends on RTD growth, innovation, emerging markets and a potential recovery in Canada, while the bear case centers on a prolonged decline in alcohol consumption and continued weakness across developed markets.
READ NEXT: PG&E (PCG)’s $2 Billion Spending Deferral Raises Questions Over its Growth Outlook and Wegovy’s German Debut Opens a New Front for Novo Nordisk (NVO)
Disclosure: None. This article is originally published at Insider Monkey.
